Skip to main content


Search reports, investigative results, and agency plansShowing 51 - 60 of 202 results
Department of Justice OIG

Review of the United States Marshals Service’s Response to the COVID-19 Pandemic

Department of Health & Human Services OIG

Opioid Use in Medicare Part D During the Onset of the COVID-19 Pandemic

Concerns about the use of opioids in Medicare Part D and the availability of treatment for opioid use disorder have heightened with the onset of the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 poses specific dangers for people using opioids, as respiratory diseases like COVID-19 can increase the risk of fatal overdose among those taking opioids and those with opioid use disorder are more likely to contract COVID-19 and suffer complications. It is imperative that the Department of Health and Human Services (HHS) closely monitor opioid use during this unprecedented time. From 2016 to...

Department of Veterans Affairs OIG

Medication Delivery Delays Prior to and During the COVID-19 Pandemic at the Manila Outpatient Clinic in Pasay City, Philippines

The VA Office of Inspector General (OIG) conducted an inspection to assess allegations related to delayed medication delivery from the VA Manila Outpatient Clinic (clinic) pharmacy in Pasay City, Philippines, prior to and during the COVID-19 pandemic. The OIG substantiated a patient experienced medication delivery delays and did not timely receive morphine from the clinic pharmacy in October and November 2019. While the patient requested a renewal in a timely manner, pharmacists could not fill the medication because there was no available stock from the Veterans Health Administration’s (VHA)...